OIG175664__synopsis_solicitation_review_06142016.pdf

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.

(ii) The solicitation number is OIG175664. The solicitation is issued as a Request for

Quote (RFQ)

(iii) This solicitation and incorporated provisions and clauses are those in effect through

Federal Acquisition Circular 2005-88.

(iv) The corresponding NAICS code is 511210 and the small business size standard is

$38.5 million.

(v) List of contract line item number(s) and items, quantities and units of measure –

Base Period:

Line Item Description Quantity

1 Micromedex Web Ready Content | FFDOWN Subscription |

M | Users Summary Drug Info Metatags

2. Micromedex Healthcare Series | INTERNET Subscription |

M | Users Drug Points, Drug Identification, Summary Drug

Information.

Option Period 1:

1 Micromedex Web Ready Content | FFDOWN Subscription |

M | Users Summary Drug Info Metatags

2. Micromedex Healthcare Series | INTERNET Subscription |

M | Users Drug Points, Drug Identification, Summary Drug

Option Period 2:

1 Micromedex Web Ready Content | FFDOWN Subscription |

M | Users Summary Drug Info Metatags

2. Micromedex Healthcare Series | INTERNET Subscription |

M | Users Drug Points, Drug Identification, Summary Drug

Option Period 3:

1 Micromedex Web Ready Content | FFDOWN Subscription |

M | Users Summary Drug Info Metatags

2. Micromedex Healthcare Series | INTERNET Subscription |

M | Users Drug Points, Drug Identification, Summary Drug

Option Period 4:

1 Micromedex Web Ready Content | FFDOWN Subscription |

M | Users Summary Drug Info Metatags

2. Micromedex Healthcare Series | INTERNET Subscription |

M | Users Drug Points, Drug Identification, Summary Drug

(vi) Description of Requirements –This is a renewal and brand name requirement for

Truven Health Analytics Drug Points and DrugDex subscriptions only. The subscription is required because it contains all the necessary information for the Office of the

Inspector General (OIG) to complete its ongoing work involving off-label use of cancer drugs in Medicate Part B, as well as planned work in Part D and Medicaid. The subscription is used in conjunction with other compendia, already purchased, to determine “off-label” use of prescription drugs meets certain criteria.

(vii) Delivery and all services are to be delivered FOB to Washington, DC. The period of performance shall be for a 12-month base period and four 12-month option periods, as follows:

Base Period: 06/01/2016 – 05/31/2017

Option Period 1: 06/01/2017 – 05/31/2018

Option Period 2: 06/01/2018 – 05/31/2019

Option Period 3: 06/01/2019 – 05/31/2020

Option Period 4: 06/01/2020 – 05/31/2021

(viii) The provision at FAR 52.212-1, Instructions to Offerors – Commercial Items, applies to this acquisition.

(ix) The provision at FAR 52.212-2, Evaluation – Commercial Items, applies to this acquisition. The Government will award a contract resulting from this synopsis/solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered.

(x) Offerors are to include a completed copy of the provision at FAR 52.212-3, Offeror

Representations and Certifications – Commercial Items.

(xi) The clause at FAR 52.212-4, Contract Terms and Conditions – Commercial Items, applies to this acquisition.

(xii) The clauses at FAR 52.212-5, Contract Terms and Conditions Required to

Implement Statutes or Executive Orders – Commercial Items, applies to this acquisition.

The Contracting Officer has indicated the following clauses listed in paragraph (b) as applicable and are hereby incorporated by reference: (4) 52.204-10, Reporting Executive compensation and First-Tier Subcontract Awards (Oct 2015) (Pub. L. 109-282) (31

U.S.C. 6101 note); (8) 52.209-6, Protecting the Government’s Interest When

Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment (Oct

2015) (31 U.S.C. 6101 note); (9) 52.209-9, Updates of Publicly Available Information

Regarding Responsibility Matters (Jul 2013) (41 U.S.C. 2313); (22) 52.219-28, Post

Award Small Business Program Rerepresentation (Jul 2013) (15 U.S.C. 632(a)(2)); (25)

52.222-3, Convict Labor (June 2003) (E.O. 11755); (26) 52.222-19, Child Labor—

Cooperation with Authorities and Remedies (Feb 2016) (E.O. 13126); (27) 52.222-21, Prohibition of Segregated Facilities (Apr 2015); (28) 52.222-26, Equal Opportunity (Apr

2015) (E.O. 11246); (30) 52.222-36, Equal Opportunity for Workers with Disabilities

(Jul 2014) (29 U.S.C. 793); (33) (i) 52.222-50, Combating Trafficking in Persons (Mar

2015) (22 U.S.C. chapter 78 and E.O. 13627); (40) 52.223-18, Encouraging Contractor

Policies to Ban Text Messaging while Driving (Aug 2011) (E.O. 13513); (44) 52.225-13, Restrictions on Certain Foreign Purchases (Jun 2008) (E.O.’s, proclamations, and statutes administered by the Office of Foreign Assets Control of the Department of the Treasury);

(50) 52.232-33, Payment by Electronic Funds Transfer— System for Award Management

(Jul 2013) (31 U.S.C. 3332).

(xiii) The following Federal Acquisition Regulation (FAR) and Health and Human

Services Acquisition Regulations (HHSAR) clauses also apply: FAR 52.217-9; Option to

Extend the Term of the Contract; HHSAR 352.222-70, Contractor Cooperation in Equal

Employment Opportunity Investigations; HHSAR 352.239-74, Electronic and

Information Technology Accessibility (fill in 1194.21, Software Applications and

Operating Systems).

(xiv) DPAS – N/A

(xv) Quotes are due Thursday, June 23 by 2:00 pm, EST, electronically to the Contract

Specialist at Ingrid.Walker@psc.hhs.gov

(xvi) Contact Mrs. Ingrid Walker, Contract Specialist, at Ingrid.Walker@psc.hhs.gov regarding the solicitation. Any inquiries must be emailed to the Contract Specialist, with

“OIG175664- Truven Health Analytics – Inquiries” in the subject line.